Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CELEBRATION, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company...
Morning Movers
B. Riley Financial Receives Nasdaq Staff Determination Letter; Will Seek Hearing & Continued Listing
LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (Nasdaq: RILY) (the "Company") today announced that, on October 1,...
AES Announces Third Quarter 2025 Financial Review Conference Call to be Held on Wednesday, November 5, 2025 at 10:00 a.m. ET
ARLINGTON, Va., Oct. 6, 2025 /PRNewswire/ -- The AES Corporation (NYSE: AES) will host a conference call on Wednesday, November 5,...
Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for...
FLAGSTAR FINANCIAL, INC. ANNOUNCES RECEIPT OF REQUIRED REGULATORY APPROVALS TO MERGE HOLDING COMPANY INTO ITS BANK
HICKSVILLE, N.Y., Oct. 6, 2025 /PRNewswire/ -- Flagstar Financial, Inc. (NYSE: FLG) (the "Company") today announced it has received the...
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA’S HILLCOUR INVESTMENT FUND
A Total of $1.7 Million Raised in Q3 2025 TAMPA, Fla., Oct. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or...
Trilogy Metals Announces Strategic Investment by US Federal Government
This news release constitutes a "designated news release" for the purposes of Trilogy Metals Inc.'s prospectus supplement dated May 27,...
Kimberly-Clark to Announce Third Quarter 2025 Results on October 30, 2025
DALLAS, Oct. 6, 2025 /PRNewswire/ -- Kimberly-Clark (NASDAQ: KMB) will issue its third quarter 2025 results on Thursday, October 30. A...
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
New LEQEMBI CompanionTM program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide...
Solaris Energy Infrastructure, Inc. Announces Proposed Convertible Senior Notes Offering
HOUSTON--(BUSINESS WIRE)--Solaris Energy Infrastructure, Inc. (“Solaris”) (NYSE: SEI) today announced its intention to offer, subject to market and other conditions,...
Sealed Air to Hold Conference Call to Discuss Third Quarter 2025 Results
CHARLOTTE, N.C., Oct. 6, 2025 /PRNewswire/ -- Sealed Air Corporation (NYSE: SEE) announced today that it will release its third quarter...
Equillium Announces Leadership and Corporate Updates
LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep...
Ellington Financial Announces Closing of Senior Unsecured Notes Offering
OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced that it has closed its offering of $400...
VINCI COMPASS ANNOUNCES ACQUISITION OF 50.1% STAKE IN VERDE ASSET MANAGEMENT, BUILDING THE REGION’S LEADER IN GLOBAL AND LOCAL ASSET ALLOCATION
Vinci Compass will acquire the remaining 49.9% stake five years after Closing. Verde Asset Management brings R$16 billion in assets...
SEALSQ Enters into Warrant Exercise Transaction for $69.0 Million in Gross Proceeds
Geneva, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on...
Biomea Fusion Announces Proposed Public Offering of Securities
SAN CARLOS, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity...
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient...
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
Los Angeles, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the...
Serve Robotics Deploys 1,000th Autonomous Delivery Robot
SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today...
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company...
Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company advancing a yield...
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to...
Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
- Results published in Oxford Academic’s Military Medicine Journal - - After up to 18 months of follow-up patients were...
Fannie Mae Announces Results of Tender Offer for Any and All of Certain CAS Notes
WASHINGTON, Oct. 6, 2025 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) today announced the results of its fixed-price cash tender offers (each,...
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Full Year 2024 and First Half 2025 Financial Results
ROCHESTER, NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX),...
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participants Plasma exposures in patients...
URANIUM ENERGY CORP ANNOUNCES THE CLOSING OF $203 MILLION PUBLIC OFFERING
NYSE American: UEC Proceeds to be Used to Accelerate the Development of the United States Uranium Refining & Conversion Corp CORPUS CHRISTI, Texas,...
Blackbaud Unveils Seismic Shifts in AI Innovation, Rolling Out 70+ Embedded, Sector-Specific Capabilities and Unlocking New Possibility for Social Impact
Bold New Initiatives and Connected Intelligent Systems Aim to Make the Artificial Intelligence Promise Real for the Organizations Tackling the...
Airship AI Announces $11.0 Million of Firm Fixed Price Brand Name Only Awards from US Federal Law Enforcement Agencies in September
Public Safety and Homeland Security Macro Tailwinds Remain Strong Heading into the US Federal Government’s Fiscal First Quarter REDMOND, Wash.,...
RETRANSMISSION: HIVE Digital Technologies September Bitcoin Production at 267 BTC, Climbs 8% MoM and 138% YoY, Surpassing 21 EH/s and Now Producing 9 BTC Per Day
This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated...
HIVE Digital Technologies September Bitcoin Production at 267 BTC, Climbs 8% MoM and 138% YoY, Surpassing 21 EH/s and Now Producing 9 BTC Per Day
This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated...
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials...
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/...
Graphite One Welcomes Strategic Investment from Doyon Limited and Aleut
Doyon and Aleut have made an investment totaling US$5.0 million in Graphite One, fully supporting the development of the Graphite...
Construction Partners, Inc. Completes Texas Acquisition
Company Adds Eight Hot-Mix Asphalt Plants in Houston Metro Area DOTHAN, Ala., Oct. 6, 2025 /PRNewswire/ -- Construction Partners, Inc....
Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society
SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new...
QYOU Media Subsidiary Chatterbox Technologies Completes Successful India IPO
Oversubscribed Issue Drives 17% Two Day Gain From Top End of Initial Pricing Over 2.1M Shares Traded Representing Buying of...
FedEx Announces Marshall Witt as Senior Vice President and Chief Financial Officer of FedEx Freight
MEMPHIS, Tenn.--(BUSINESS WIRE)--FedEx Corp. (NYSE: FDX) today announced that Marshall Witt, formerly the chief financial officer of TD SYNNEX, a...
NexPoint Residential Trust, Inc. Announces Third Quarter 2025 Earnings Conference Call
DALLAS, Oct. 6, 2025 /PRNewswire/ -- NexPoint Residential Trust, Inc. ("NXRT" or the "Company") (NYSE: NXRT) announced today that the...
NexPoint Real Estate Finance, Inc. Announces Third Quarter 2025 Earnings Conference Call
DALLAS, Oct. 6, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the "Company") announced today that the Company...